-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lyme disease neuropathic (LNB) usually presents with painful meningeal radiculitis and/or cranial neuritis with discomfort and fatigue
Recommendations regarding the duration of treatment are divided
The trial was randomized, double-blind, placebo-controlled
Research Process
Secondary endpoints were CCS at 10 weeks and 12 months, CSF results at 6 months and 12 months, safety measured by blood tests (hematology values, kidney and liver function) at 2 months and 4 months Patients reported outcome measures (PROMs) and weekly reported side effects in a 10-week patient diary a few weeks after initiation of sexual and tolerable therapy
Combined clinical scores for both treatment groups throughout the study
A total of 121 patients were included
The results showed no benefit of doxycycline treatment beyond 2 weeks